|
Status |
Public on Feb 19, 2024 |
Title |
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B-cell fate decisions and accelerates development of T-cell depleted lymphomas. |
Organisms |
Homo sapiens; Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
38570506 |
|
Submission date |
Feb 03, 2023 |
Last update date |
Apr 17, 2024 |
Contact name |
Christopher Russell Chin |
E-mail(s) |
chc2077@med.cornell.edu
|
Phone |
3393640514
|
Organization name |
Weill Cornell
|
Lab |
Melnick Lab
|
Street address |
413 E 69th Street, Belfer Building, BB-1462
|
City |
New York City |
State/province |
NY |
ZIP/Postal code |
10021 |
Country |
USA |
|
|
Platforms (3) |
GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (143)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE224465 |
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B-cell fate decisions and accelerates development of T-cell depleted lymphomas [RNA-Seq] |
GSE224512 |
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B-cell fate decisions and accelerates development of T-cell depleted lymphomas [ATAC-seq] |
GSE224781 |
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B-cell fate decisions and accelerates development of T-cell depleted lymphomas (Cut&Run) |
GSE224782 |
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B-cell fate decisions and accelerates development of T-cell depleted lymphomas (scRNA-Seq) |
GSE260809 |
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B-cell fate decisions and accelerates development of T-cell depleted lymphomas [WES] |
GSE260810 |
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B-cell fate decisions and accelerates development of T-cell depleted lymphomas [CapIG-seq] |
GSE260811 |
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B-cell fate decisions and accelerates development of T-cell depleted lymphomas [Mint-ChIP] |
|
Relations |
BioProject |
PRJNA931359 |